First effective treatment for chemotherapy-induced peripheral neuropathy

Afatinib delays progression of advanced lung adenocarcinomas

Costly drugs versus paclitaxel as first line therapy for locally advanced or metastatic breast cancer

Routine molecular testing of non-small cell lung cancers in community settings

Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies

Better taking of family histories and referral to genetic counselling

EMILIA trial: Trastuzumab emtansine improves progression-free survival in HER2-positive breast cancer

Increased progression-free survival in advanced lung cancer with afatinib

Intermittent hormonal therapy versus continuous therapy for advanced prostate cancer

Changing the standard treatment for lymphoma with bendamustine

Trastuzumab emtansine improves progression-free survival for HER2-positive breast cancer

Continuing bevacizumab with second-line chemotherapy for colorectal cancer